Reply to Gargiulo et al.: Dose-stratified real-world effectiveness of JAK1 inhibitors in atopic dermatitis
Abstract
Dear EditorWe thank Luigi Gargiulo and colleagues for their thoughtful correspondence regarding our multicenter real-world cohort evaluating dose-stratified outcomes with abrocitinib (100/200 mg) a...
Fields of Study & Subjects
Dermatology and Skin Diseases
Asthma and respiratory diseases
Psoriasis: Treatment and Pathogenesis
Publication details
- Journal / source
- Journal of Dermatological Treatment
- Volume
- 37
- Issue
- 1
- Pages
- 2627103–2627103
- Publication date
- 16 February 2026
- Language
- EN